BRPI0001672A8 - composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade - Google Patents

composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade

Info

Publication number
BRPI0001672A8
BRPI0001672A8 BRPI0001672A BRPI0001672A BRPI0001672A8 BR PI0001672 A8 BRPI0001672 A8 BR PI0001672A8 BR PI0001672 A BRPI0001672 A BR PI0001672A BR PI0001672 A BRPI0001672 A BR PI0001672A BR PI0001672 A8 BRPI0001672 A8 BR PI0001672A8
Authority
BR
Brazil
Prior art keywords
plant sterol
composition
isoflavone
protein material
weight
Prior art date
Application number
BRPI0001672A
Other languages
English (en)
Portuguese (pt)
Inventor
H Waggle Doyle
C Henley E
M Potter Susan
Original Assignee
Archer Daniels Midland Co
Protein Tech International Inc
Solae Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archer Daniels Midland Co, Protein Tech International Inc, Solae Llc filed Critical Archer Daniels Midland Co
Publication of BRPI0001672A2 publication Critical patent/BRPI0001672A2/pt
Publication of BRPI0001672A8 publication Critical patent/BRPI0001672A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
BRPI0001672A 1999-04-23 2000-04-20 composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade BRPI0001672A8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/298,528 US6544566B1 (en) 1999-04-23 1999-04-23 Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol

Publications (2)

Publication Number Publication Date
BRPI0001672A2 BRPI0001672A2 (US20050276830A1-20051215-C00018.png) 2001-08-21
BRPI0001672A8 true BRPI0001672A8 (pt) 2018-12-26

Family

ID=23150910

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0001672A BRPI0001672A8 (pt) 1999-04-23 2000-04-20 composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade
BR0001672-1A BR0001672A (pt) 1999-04-23 2000-04-20 Composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR0001672-1A BR0001672A (pt) 1999-04-23 2000-04-20 Composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade

Country Status (10)

Country Link
US (4) US6544566B1 (US20050276830A1-20051215-C00018.png)
EP (1) EP1046396A3 (US20050276830A1-20051215-C00018.png)
JP (1) JP2000344676A (US20050276830A1-20051215-C00018.png)
KR (2) KR100408212B1 (US20050276830A1-20051215-C00018.png)
AU (1) AU748782B2 (US20050276830A1-20051215-C00018.png)
BR (2) BRPI0001672A8 (US20050276830A1-20051215-C00018.png)
CA (1) CA2306008C (US20050276830A1-20051215-C00018.png)
MX (1) MXPA00003979A (US20050276830A1-20051215-C00018.png)
RU (1) RU2205015C2 (US20050276830A1-20051215-C00018.png)
TW (4) TW200404563A (US20050276830A1-20051215-C00018.png)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT656786E (pt) 1992-05-19 2004-11-30 Novogen Res Pty Ltd Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6790669B1 (en) * 1999-07-13 2004-09-14 The Dow Chemical Company Method for chemical analysis of biological material
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
CN1165244C (zh) * 1999-10-28 2004-09-08 味之素株式会社 大豆胚芽油及生产富含胚芽的大豆原料的方法
US6677327B1 (en) 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
KR20030005280A (ko) 2000-04-14 2003-01-17 마아즈, 인코오포레이티드 혈관의 건강을 개선하기 위한 조성물과 방법
EP1289556B1 (en) * 2000-06-14 2007-06-06 The United States of America, represented by The Secretary, Dept. of Health and Human Services, the Natl. Institutes of Health Isoflavones against radiation-induced mortality
AU2002225920A1 (en) 2000-11-09 2002-05-21 Cargill Incorporated Soybean processing
KR20020037140A (ko) * 2000-11-13 2002-05-18 권승룡 지질 저하 활성을 갖는 플라보노이드를 포함하는 터몹시스알터니플로라 추출물 및 이를 유효 성분으로 하는 약학적조성물
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
AU2008200518B2 (en) * 2001-03-16 2010-04-01 Novogen Research Pty Ltd Treatment of restenosis
AU2006200292B2 (en) * 2001-03-16 2007-11-22 Novogen Research Pty Ltd Treatment of restenosis
US6773733B2 (en) * 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
KR20020081835A (ko) * 2001-04-20 2002-10-30 주식회사 유엘바이오텍 혈중 콜레스테롤 저하용 복합 조성물의 제조방법과 이에의해 제조한 복합조성물
JP4609875B2 (ja) * 2001-07-31 2011-01-12 有限会社大長企画 健康食品
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
GB0125662D0 (en) * 2001-10-26 2001-12-19 Chapman Thomas B Formultion
JP5384777B2 (ja) * 2001-12-18 2014-01-08 有限会社大長企画 強筋肉剤、抗炎症剤
FI20012553A0 (fi) * 2001-12-21 2001-12-21 Raisio Benecol Oy Syötävät koostumukset
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
NZ536466A (en) * 2002-04-18 2008-04-30 Monsanto Technology Llc Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
CA2492754C (en) 2002-07-24 2018-05-22 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
CA2504682A1 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
KR100994632B1 (ko) * 2002-12-27 2010-11-15 (주)아모레퍼시픽 Ｃｐｔ-１ 유전자의 발현을 특이적으로 전사 단계에서조절하는 화학물질의 스크리닝 방법 및 그 방법으로검색된 제니스테인을 유효 성분으로 포함하는 ｃｐｔ-１발현 촉진제
US20050037102A1 (en) * 2003-07-18 2005-02-17 Barrie Tan Annatto extract compositions including tocotrienols and tocopherols and methods of use
CN101690722B (zh) * 2003-04-24 2011-09-14 株式会社太平洋 减肥组合物
US20070003600A1 (en) * 2003-06-11 2007-01-04 Carolyn Moore Methods for reducing c-reactive protein
JP2005139150A (ja) * 2003-11-10 2005-06-02 Api Co Ltd エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
US20050220949A1 (en) * 2004-03-31 2005-10-06 Blas Arzubi Highly bioefficient isoflavone-phospholipid molecular complexes and methods of making and using the same
EP1740191A4 (en) * 2004-04-28 2008-07-30 Univ Brigham Young USE OF EQUOL FOR THE TREATMENT OF SKIN DISEASES
US7399490B2 (en) * 2004-05-17 2008-07-15 Lean For Life, Inc. Compositions containing a nopal cactus isolate and method for making same
US20050281932A1 (en) * 2004-06-18 2005-12-22 Good Humor - Breyers Ice Cream Frozen confection
US7659242B2 (en) * 2004-07-19 2010-02-09 Thia Medica As Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities
US6998397B2 (en) * 2004-07-23 2006-02-14 Drebsk Comptech, Inc. Method for decreasing cholesterol level in blood
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
DE602006016741D1 (de) * 2005-02-15 2010-10-21 Dsm Ip Assets Bv Zusammensetzungen mit polysacchariden
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
JP4410177B2 (ja) * 2005-09-21 2010-02-03 株式会社日立製作所 情報記録再生方法及び情報記録再生装置
US20070134395A1 (en) * 2005-12-13 2007-06-14 Hodges Everett L Method of reducing manganese in defatted soy isolate
US20070196515A1 (en) * 2006-02-22 2007-08-23 Kothari Shil C Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome X
EP1991064A1 (en) 2006-03-03 2008-11-19 Specialty Protein Producers, Inc. Methods of separating fat from non-soy plant materials and compositions produced therefrom
US20070207254A1 (en) * 2006-03-03 2007-09-06 Specialty Protein Producers, Inc. Methods of separating fat from soy materials and compositions produced therefrom
EP1998631A2 (en) * 2006-03-03 2008-12-10 Specialty Protein Producers, Inc. Plant-derived protein compositions
EP2007227A2 (en) * 2006-04-13 2008-12-31 Cammedica Limited Lycopene for the treatment of metabolic dysfunction
KR100758582B1 (ko) * 2006-04-26 2007-09-13 조남지 유지 대체 조성물
US20070299017A1 (en) * 2006-06-23 2007-12-27 Kanter Mitchell M Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements
JP3944864B1 (ja) * 2006-07-31 2007-07-18 株式会社Ｊ−オイルミルズ メタボリックシンドロームの予防および改善用組成物
EP2641608B1 (en) * 2006-09-16 2015-03-04 SOY Labs LLC Pharmaceutical composition comprising lunasin enriched seed extract and soy flour
US9101161B2 (en) 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
US20090093406A1 (en) * 2007-09-10 2009-04-09 Solae, Llc Vegetable Protein Concentrate Having a Reduced Insoluble Dietary Fiber Content and Increase Amount of Soluble Dietary Fiber Content
US20090176871A1 (en) * 2008-01-07 2009-07-09 Schoenwetter Phillip E Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones
CA2712446A1 (en) * 2008-01-22 2009-07-30 Hamlet Protein A/S Composition comprising protein and disperse fat
US8716249B2 (en) * 2008-01-31 2014-05-06 Energy Light Llc Compositions and methods for improving cardiovascular health
DE202008008165U1 (de) 2008-06-18 2009-11-05 Tridonicatco Gmbh & Co. Kg Betriebsgerät für Gasentladungslampen oder andere Leuchtmittel mit Lampenstrommessung
US20100068346A1 (en) * 2008-09-16 2010-03-18 Hodges Everett L Infant formula
US8799827B2 (en) * 2010-02-19 2014-08-05 Microsoft Corporation Page manipulations using on and off-screen gestures
JP5077461B2 (ja) 2010-06-07 2012-11-21 不二製油株式会社 減脂豆乳及び大豆乳化組成物、並びにそれらの製造法
FR2978452B1 (fr) * 2011-07-28 2015-01-30 Expanscience Lab Extraction liquide / liquide avec un solvant comprenant au moins 5 atomes de carbone et 1 ou 2 atomes d'oxygene
US11331328B2 (en) 2014-05-05 2022-05-17 Bioventures, Llc Compositions and methods for inhibiting antiapoptotic Bcl-2 proteins as anti-aging agents
CA2955972A1 (en) 2014-07-22 2016-01-28 Bioventures, Llc. Compositions and methods for selectively depleting senescent cells
EA038520B1 (ru) * 2015-05-07 2021-09-09 Онкоиммьюн, Инк. Применение гуманизированного слитого белка cd24 для снижения уровней холестерина липопротеинов низкой плотности
US11571002B2 (en) 2016-04-22 2023-02-07 Ripple Foods, Pbc Dairy product analogs and processes for making same
WO2020210194A1 (en) * 2019-04-08 2020-10-15 Corn Products Development, Inc. Improved plant-protein based analog dairy compositions
US20220248707A1 (en) * 2019-07-16 2022-08-11 Advanced Female Technologies Llc Chewing gum compositions for the treatment of menopausal symptoms

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870805A (en) 1970-11-04 1975-03-11 Staley Mfg Co A E Process for preparing texturized protein compositions and the resulting product
JPS4810076U (US20050276830A1-20051215-C00018.png) 1971-06-17 1973-02-03
BE792826A (fr) * 1971-12-16 1973-03-30 Intellectual Property Dev Corp Composition et procede pour abaisser les taux de cholesterol etde lipides chez les mammiferes
JPS4927872A (US20050276830A1-20051215-C00018.png) 1972-07-07 1974-03-12
JPS5328929A (en) 1976-08-31 1978-03-17 Seibu Kensetsu Kk Starting method of vertical shaft of muddy water pressurizing system tunnel excavator
US4157984A (en) 1977-06-08 1979-06-12 Z-L Limited Antioxidants, antioxidant compositions and methods of preparing and using same
FI57956C (fi) 1978-12-12 1980-11-10 Farmos Oy Foerfarande foer isolering av beta-sitosterol med laog alfa-sitosterolhalt
FI59416C (fi) 1979-11-19 1981-08-10 Farmos Oy Foerfarande foer utvinning av beta-sitosterol ur en sterolblandning utvunnen fraon raosaopans neutralfraktion
JPS5822195B2 (ja) 1980-11-12 1983-05-07 大日本インキ化学工業株式会社 新規な酵母菌
JPS5933232A (ja) 1982-08-19 1984-02-23 Tokiwa Kanpou Seiyaku:Kk マメ科植物からサポニン類およびフラボン類の分離方法
JPS5985265A (ja) 1982-11-04 1984-05-17 Naganoken Kooridoufu Kogyo Kyodo Kumiai 栄養強化食品素材の製造法
JPS59137421A (ja) 1983-01-28 1984-08-07 Naganoken Kooridoufu Kogyo Kyodo Kumiai 生理活性物質の製造法
JPS59232052A (ja) 1983-06-14 1984-12-26 Ajinomoto Co Inc 改良された大豆蛋白含有素材の製造法
JPS6236163A (ja) 1985-08-12 1987-02-17 Kazue Mita ダイエツト食品
JPS62126186A (ja) 1985-11-28 1987-06-08 Tsumura Juntendo Inc イソフラボン誘導体含有溶液の製造方法
US4654011A (en) 1986-02-20 1987-03-31 Downs Arthur R Flower garden
JPS63245648A (ja) 1987-04-01 1988-10-12 Ajinomoto Co Inc 大豆食品素材の製法
US4889921A (en) 1987-04-29 1989-12-26 The University Of Toronto Innovations Foundation Production of rapeseed protein materials
JPH0634526B2 (ja) 1987-10-05 1994-05-02 シャープ株式会社 立体映像処理装置
JPH0714927B2 (ja) 1988-04-06 1995-02-22 キッコーマン株式会社 イソフラボン化合物の製造法
JPH0223822A (ja) 1988-07-13 1990-01-26 Kaneko Shiyubiyou Kk 培養苗の順化方法とその装置
JP2753719B2 (ja) 1988-12-15 1998-05-20 日本油脂株式会社 リポソーム製剤の製造法
JPH0347049A (ja) 1989-03-09 1991-02-28 Sanyu:Kk 豆腐廃液ゆからの食品素材及び健康飲料の製造方法
CH679584A5 (US20050276830A1-20051215-C00018.png) 1989-11-10 1992-03-13 Nestle Sa
JPH0436242A (ja) 1990-05-30 1992-02-06 Fuji Oil Co Ltd 大豆サポニンの製造法
JP2754872B2 (ja) 1990-05-31 1998-05-20 キヤノン株式会社 像ぶれ防止装置
JPH04238518A (ja) 1991-01-23 1992-08-26 Tokyo Electric Co Ltd Ｒｓ−４２２平衡回線の極性選択装置
JPH0645634B2 (ja) 1991-02-21 1994-06-15 阿保 定吉 大豆イソフラボン配糖体
JPH04283518A (ja) 1991-03-12 1992-10-08 Kikkoman Corp 抗歯周症剤
JP3047049B2 (ja) 1991-10-07 2000-05-29 日本電信電話株式会社 埋込み構造半導体レーザの製造方法
JPH05170756A (ja) 1991-12-20 1993-07-09 Kikkoman Corp イソフラボン化合物の製造法
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
PT656786E (pt) 1992-05-19 2004-11-30 Novogen Res Pty Ltd Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo
JPH06287554A (ja) 1993-04-01 1994-10-11 Aomori Pref Gov 大豆粕叉はおからからの抗酸化性物質の製造方法
CH685283A5 (it) * 1993-09-21 1995-05-31 Inpharma Sa Composizioni dietetiche ipocolesterolemizzanti.
US5320949A (en) 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
US6140469A (en) 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
CN1055931C (zh) 1993-10-12 2000-08-30 蛋白质技术国际公司 富含糖苷配基异黄酮植物蛋白浓缩物及其制备方法
JP3777390B2 (ja) 1993-10-12 2006-05-24 アーチャー ダニエルズ ミッドランド カンパニー アグルコンイソフラボン濃縮植物タンパク質抽出物及び単離物並びにその製造方法
US5637561A (en) 1993-10-12 1997-06-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing
US5589182A (en) 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5506211A (en) 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
AU3689095A (en) 1994-10-03 1996-04-26 Schouten Industries B.V. Food and health products
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5523087A (en) * 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
JP3383718B2 (ja) 1995-02-15 2003-03-04 ニチモウ株式会社 大豆蛋白を原料とした生成物の製造方法
US5679806A (en) 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
US5545414A (en) * 1995-03-22 1996-08-13 Abbott Laboratories Cholesterol lowering food product
JPH08283283A (ja) 1995-04-14 1996-10-29 Kikkoman Corp マロニルイソフラボン配糖体及び該物質からイソフラボン配糖体又はイソフラボンアグリコンを取得する方法
US5827682A (en) 1995-06-07 1998-10-27 Protein Technologies International, Inc. Two-step conversion of vegetable protein isoflavone conjugates to aglucones
JPH0923822A (ja) 1995-07-14 1997-01-28 Nichimo Co Ltd ペプチド生成物およびその製造方法
IL115110A (en) 1995-08-30 1997-08-14 Chajuss Daniel Soy molasses
US5670632A (en) 1996-01-18 1997-09-23 Acds Technologies, Ltd. Process for obtaining an isoflavone concentrate from a soybean extract
JPH09255570A (ja) * 1996-03-21 1997-09-30 Fujitsuko Kk 血中脂質濃度を低減させる薬剤及び可食性組成物
US5851792A (en) 1996-04-03 1998-12-22 Shen; Jerome Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey
US6248378B1 (en) * 1998-12-16 2001-06-19 Universidad De Sevilla Enhanced food products
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
AU3887597A (en) * 1996-07-18 1998-02-10 Nutricor, Inc. Nutritious food preparations and methods for making them
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
FI120290B (fi) * 1996-12-30 2009-09-15 Mirador Res Oy Ltd Menetelmä, jonka avulla voidaan valmistaa sellaisia mausteseos-, ruoan ainesosa- ja elintarvikekoostumuksia, jotka alentavat seerumin kolesterolia
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
US5855892A (en) 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5994508A (en) 1998-04-13 1999-11-30 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
US6083553A (en) 1998-06-05 2000-07-04 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
US6013771A (en) 1998-06-09 2000-01-11 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
AU767245B2 (en) 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
JP2003524610A (ja) 1998-11-25 2003-08-19 ニュートリ・ファーマ・アルメント・アクシェセルスカブ 大豆蛋白質、食物繊維およびフィトエストロゲン化合物を含む組成物、および２型糖尿病、代謝症候群および関連する心臓血管疾患の予防および／または治療におけるその使用
US6113972A (en) 1998-12-03 2000-09-05 Monsanto Co. Phytosterol protein complex
US6241996B1 (en) * 1999-04-09 2001-06-05 Novartis Nutrition Ag Liquid soy nutritional products

Also Published As

Publication number Publication date
CA2306008C (en) 2004-08-10
BR0001672A (pt) 2001-08-21
US20010026814A1 (en) 2001-10-04
TW200404563A (en) 2004-04-01
TWI242437B (en) 2005-11-01
AU2771400A (en) 2000-11-23
TW200405816A (en) 2004-04-16
US6572876B2 (en) 2003-06-03
MXPA00003979A (es) 2002-03-08
KR100408212B1 (ko) 2003-12-01
JP2000344676A (ja) 2000-12-12
BRPI0001672A2 (US20050276830A1-20051215-C00018.png) 2001-08-21
TW200406218A (en) 2004-05-01
US20010024666A1 (en) 2001-09-27
KR20010020768A (ko) 2001-03-15
KR20030005107A (ko) 2003-01-15
US20010029248A1 (en) 2001-10-11
KR100473919B1 (ko) 2005-03-10
US6579534B2 (en) 2003-06-17
US6544566B1 (en) 2003-04-08
US6669952B2 (en) 2003-12-30
RU2205015C2 (ru) 2003-05-27
EP1046396A2 (en) 2000-10-25
CA2306008A1 (en) 2000-10-23
AU748782B2 (en) 2002-06-13
EP1046396A3 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
BRPI0001672A8 (pt) composição e método para redução da cocentração de colesterol lipoprotéico de baixa densidade
Heim et al. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships
Toda et al. Inhibitory effects of isoflavones on lipid peroxidation by reactive oxygen species
Mitchell et al. Antioxidant efficacy of phytoestrogens in chemical and biological model systems
Terahara Flavonoids in foods: a review
Ader et al. Bioavailability and metabolism of the flavonol quercetin in the pig
Hubert et al. Effects of fermentation on the phytochemical composition and antioxidant properties of soy germ
Day et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity
Thiagarajan et al. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium
Okawa et al. DPPH (1, 1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants
Turner et al. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein
Isanga et al. Soybean bioactive components and their implications to health—a review
Pelissero et al. Effects of flavonoids on aromatase activity, an in vitro study
Tiwari Imbalance in antioxidant defence and human diseases: Multiple approach of natural antioxidants therapy
Hooper et al. A review of the health care potential of bioactive compounds
EP0903143A3 (en) Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels
ATE514345T1 (de) Zusammensetzung zur senkung des blutcholesterolspiegels
WO2000003684A3 (en) Soy formulations and their use for promoting health
RU2000109723A (ru) Композиция и способ для снижения концентрации холестерина липопротеина низкой плотности
TR200002770T2 (tr) Estrojene bağlı bozuklukların tedavisi
WO2002043506A3 (en) Cholesterol lowering supplement
BR9915687A (pt) Composição compreendendo proteìna de soja,fibras de dieta e um composto fitoestrogênio eseu uso na prevenção e/ou tratamento de doençascardiovasculares
TR199901510T2 (xx) G�da lezzetlendiricileri, g�da terkip maddeleri ve g�da �r�n� bile�imleri haz�rlama metodu, g�da lezzetlendiricileri ve bunlar�n kullan�m�
WO2004073658A3 (en) Isoflavone derivatives
Walsh et al. Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies